Drug intelligence / Profile preview

thymopeptide

Development stage
Phase 2
Modality
Peptides
Administration
Oral, Subcutaneous, Intramuscular
01

Overview

Thymopeptide is an immunomodulatory agent consisting of a mixture of peptides, such as thymosin, derived from the thymus glands of animals (e.g., calves) or produced synthetically. It is primarily used to address immune deficiencies by enhancing cellular immune function. The mechanism of action involves promoting the maturation, differentiation, and activation of T-lymphocytes, balancing T-cell subsets, and stimulating the production of cytokines like interferons and interleukins. This helps restore and regulate the immune system's ability to fight infections and diseases. In China, thymopeptide is approved and marketed in various formulations, including enteric-coated tablets and injections, for treating conditions such as chronic hepatitis B, autoimmune diseases, and as an adjunctive therapy for cancer patients undergoing chemotherapy to boost their immune response.

Brand names
Kang Si Ai
Other names
Thymic peptidesThymosin
02

Targets

TLR (Toll-like receptors)

Beyond the preview

Go deeper on thymopeptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thymopeptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call